Prostacyclin enhances the expression of LPS/INF-gamma-induced nitric oxide synthase in human monocytes

Jörg Plum1, Chunmei Huang, Bernd Grabensee

  • 1Medizinische Klinik und Poliklinik, Klinik für Nephrologie und Rheumatologie, Heinrich-Heine-Universität, Moorenstrasse 5, D-40225 Düsseldorf, Germany. plum@uni-duesseldorf.de

Nephron
|July 18, 2002
PubMed
Abstract

Insights

Prostacyclin receptor activation enhances inducible nitric oxide synthase (iNOS) expression in human monocytes. This finding suggests a role for IP receptor signaling in nitric oxide (NO) production during inflammatory conditions like peritonitis.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Biology

Background:

  • Nitric oxide (NO) is a key mediator in inflammatory processes, with elevated levels observed in peritonitis.
  • The role of human mononuclear cells in NO production via inducible NO synthase (iNOS) is debated.

Purpose of the Study:

  • To investigate how prostacyclin receptor (IP receptor) activation influences iNOS expression and NO formation in human peripheral blood monocytes.

Main Methods:

  • Human monocytes were analyzed for IP receptor mRNA expression using reverse transcriptase-polymerase chain reaction.
  • Monocytes were stimulated with cicaprost (IP receptor agonist) and/or lipopolysaccharide (LPS)/interferon gamma (IFN-γ).
  • iNOS mRNA expression and NO2- production were quantified.

Main Results:

  • Human monocytes express significant levels of IP receptor mRNA.
  • Cicaprost stimulation induced cyclic adenosine monophosphate (cAMP) formation, confirming functional IP receptor coupling.
  • LPS/IFN-γ co-stimulation increased iNOS mRNA expression, which was further significantly enhanced by cicaprost.
  • NO2- production correlated with iNOS expression, with cicaprost further increasing LPS/IFN-γ-induced NO2- levels.

Conclusions:

  • IP receptor activation, via increased cAMP, enhances LPS/IFN-γ-induced iNOS expression in human monocytes/macrophages.
  • This mechanism may contribute to elevated NO production observed in peritonitis.

Related Concept Videos